- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 02.04. | OSSDSIGN AB: OssDsign awarded long-term agreement with Premier, Inc. | 2 | Cision News | ||
| 06.02. | OssDsign AB (publ) publishes year-end report 2023 | 2 | Cision News | ||
| 24.01. | OSSDSIGN AB: 12-month data from the clinical study of OssDsign Catalyst published in Biomedical Journal of Scientific & Technical Research | 1 | Cision News | ||
| 09.01. | Karolinska Development AB (publ): Karolinska Development's portfolio company OssDsign reports exceptional clinical data for its nanosynthetic bone graft product | 193 | GlobeNewswire (Europe) | STOCKHOLM, SWEDEN, January 9, 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that the portfolio company OssDsign reports positive data from the clinical study TOP FUSION. Top-line... ► Artikel lesen | |
| 09.01. | OSSDSIGN AB: OssDsign reports exceptional data from the clinical study TOP FUSION | 1 | Cision News | ||
| 06.12.23 | Karolinska Development AB (publ): Karolinska Development's portfolio company OssDsign expects fourth-quarter revenues to exceed market estimates | 178 | GlobeNewswire (Europe) | STOCKHOLM, SWEDEN, December 6, 2023. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that the portfolio company OssDsign expects revenues for the fourth quarter of 2023 to exceed market... ► Artikel lesen | |
| 06.12.23 | OSSDSIGN AB: OssDsign's revenues for the fourth quarter of 2023 are expected to exceed market estimates | 3 | Cision News | ||
| 30.11.23 | OSSDSIGN AB: SEB Venture Capital has sold its holding in OssDsign | 3 | Cision News | ||
| 30.11.23 | OSSDSIGN AB: OssDsign changes Certified Adviser to Carnegie Investment Bank AB (publ) | 1 | Cision News | ||
| 21.11.23 | OssDsign AB (publ) publishes Q3 2023 Interim Report | 2 | Cision News |
10 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 36,620 | +0,52 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für FMC vor Quartalszahlen auf "Underweight" mit einem Kursziel von 35,40 Euro belassen. Nach einem Gespräch mit der Investor-Relations-Abteilung... ► Artikel lesen | |
| TELADOC HEALTH | 12,136 | -0,41 % | Teladoc Health, Inc.: Teladoc Health Provides Updated Start Time for First Quarter 2024 Earnings Call on April 25 | ||
| ESSILORLUXOTTICA | 203,30 | -0,29 % | UBS stuft EssilorLuxottica auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die schweizerische Großbank UBS hat die Einstufung für EssilorLuxottica nach Zahlen zum ersten Quartal auf "Neutral" mit einem Kursziel von 181 Euro belassen. Der Umsatz... ► Artikel lesen | |
| ALIGN TECHNOLOGY | 280,00 | -0,25 % | Align Technology (ALGN) to Post Q1 Earnings: What's in Store? | ||
| DEXCOM | 121,60 | -0,91 % | DexCom Aktie: Umsatzstarkes Wachstum erwartet | DexCom, ein führender Anbieter von kontinuierlichen Glukoseüberwachungssystemen (CGM), hat in den vergangenen Quartalen starke Leistungen gezeigt, wobei die Expansion des Produktportfolios und die hohe... ► Artikel lesen | |
| HIMS & HERS HEALTH | 11,195 | +0,22 % | Why Hims & Hers Stock Was Down This Week | ||
| INMODE | 16,215 | -0,76 % | InMode LTD: InMode Reports Fourth Quarter and Full Year 2023 Financial Results; Quarterly Revenue of $126.8M and Record Full Year Revenue of $492M | YOKNEAM, Israel, Feb. 13, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results... ► Artikel lesen | |
| INVITAE | 0,110 | 0,00 % | Invitae Corporation: Invitae Reports Estimated Unaudited Fourth Quarter and Full Year 2023 Financial Results | SAN FRANCISCO, March 6, 2024 /PRNewswire/ -- Invitae (OTC: NVTA), a leading medical genetics company, today announced estimated unaudited fourth quarter and full year 2023 revenue, gross profit... ► Artikel lesen | |
| ELEVANCE HEALTH | 499,80 | +0,18 % | Elevance Health Reports First Quarter 2024 Results | INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported first quarter 2024 results.
"First quarter results reflect disciplined execution of our strategic initiatives during... ► Artikel lesen | |
| TENET | 87,50 | 0,00 % | Tenet Healthcare, union coalition reach tentative deal | ||
| ARJO | 4,058 | +2,01 % | Dividendenbekanntmachungen (19.04.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABG SUNDAL COLLIER HOLDING ASA NO0003021909 0,5 NOK 0,0425 EUR ALM BRAND A/S DK0015250344 0,55 DKK 0,0737 EUR APA CORPORATION US03743Q1085 0... ► Artikel lesen | |
| BONESUPPORT | 20,320 | -3,88 % | BONESUPPORT HOLDING AB (publ) - Publishes year end report 2023 | BONESUPPORT HOLDING AB (publ), a leading company in orthobiologics for the management of bone injuries, today publishes the interim report for the fourth quarter 2023 and the full year 2023.
STRONG... ► Artikel lesen | |
| AMN HEALTHCARE SERVICES | 52,50 | +0,96 % | Ethisphere Recognizes AMN Healthcare with Compliance Leader Verification | Ethisphere's Compliance Leader Verification recognizes organizations with an outstanding commitment to achieving a best-in-class ethics and compliance program.SCOTTSDALE, AZ / ACCESSWIRE / April 1,... ► Artikel lesen | |
| FISHER & PAYKEL HEALTHCARE | 14,400 | 0,00 % | FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED: FPH to announce full year results on 29 May 2024 | ||
| CHECK-CAP | 2,100 | +5,00 % | Check-Cap Ltd - 6-K, Report of foreign issuer |
OSSDSIGN AB gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,772 Euro und damit -3,74 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
